Comment on: Ketamine use for management of vaso-occlusive pain in pediatric sickle cell disease

Pediatr Blood Cancer. 2023 Nov;70(11):e30618. doi: 10.1002/pbc.30618. Epub 2023 Aug 9.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Analgesics / therapeutic use
  • Anemia, Sickle Cell* / complications
  • Anemia, Sickle Cell* / drug therapy
  • Child
  • Humans
  • Ketamine* / therapeutic use
  • Pain / drug therapy
  • Pain / etiology

Substances

  • Ketamine
  • Analgesics